Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 16Recruiting 14Active not recruiting 5Terminated 2Withdrawn 1Not yet recruiting 1Completed 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Plasma cell 2Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Lymphoma 1Leukemia 1Burkitt Lymphoma 1

Interventions

venetoclax 38Azacitidine 24fludarabine 20Cytarabine 18Cyclophosphamide 16Specimen Handling 14blinatumomab 13Biopsy 12Busulfan 8Dexamethasone 7Melphalan 6Daunorubicin 6Whole-Body Irradiation 5Vincristine 5Thiotepa 5Methotrexate 5Decitabine 5gilteritinib 4daratumumab 4Tacrolimus 4Stem Cell Transplantation 4Magnetic Resonance Spectroscopy 4Imatinib Mesylate 4Idarubicin 4Exercise 4Blood Specimen Collection 4zanubrutinib 3selinexor 3ruxolitinib 3revumenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Immunotherapy, Adoptive × Other hematologic neoplasm × Clear all
NCT07020260 2025-06-13

PACMAN

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡